[Epidemiological study of the hepatitis C virus in our population and vaccine coverage].
OBJECTIVE
Epidemiological study of patients with chronic hepatitis C and its serological status in relation to the hepatitis A (HA) and B (HB) viruses.


METHODS
Descriptive cross-sectional study.


METHODS
Two urban health centres. Participants. 291 patients with chronic hepatitis C.


METHODS



METHODS
age, sex, year and reason for diagnosis, personal histories, alcohol intake, serological status of the HA and HB viruses and HIV, and initial level of transaminases.


RESULTS
Mean age, 55 +/- 16. Sex, 52% women. Prevalence, 0.98%. Reason for diagnosis, 41% health study, 15% study of hepatic pathology, 18% study of other pathologies. Personal histories, surgical intervention, 37.5%; intravenous drug users, 21.4%; transfusion, 14%; high-risk sexual conduct, 2.4%; health material used more than once, 2.4%; family member HC positive, 1.4%; no personal history recorded, 26.5%. Alcoholism, 17.9%. Mean transaminases: AST, 79.7 +/- 100 (9-920); ALT, 114.8 +/- 160 (6-1640). HB serological status: natural immunity, 22%; chronic, 9%; vaccine immunity, 3%; negative, 44%; not recorded, 21%. HA serological status: natural immunity, 2%; vaccine immunity, 2.5%; negative, 9%; not recorded, 87%. HIV-positive: 4.5%.


CONCLUSIONS
Prevalence was below the expected level. Knowledge of serological status needs to be improved, especially for HA. The degree of vaccine coverage in these patients for HA and HB should be increased.
Martínez Adell
M A
MA
Especialistas en Medicina Familiar y Comunitaria. ABS Florida Nord. DAP L'Hospitalet de Llobregat. Barcelona. España. 29201mam@comb.es
Vives Argilagós
A
A
Sibera Aresté
F X
FX
Navarrete Durán
P
P
Barro Lugo
S
S
Urbina García
P
P
D000328:Adult; D000368:Aged; D003430:Cross-Sectional Studies; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification*; D035922:Hepatitis A Antibodies / Q000097:blood*; D022362:Hepatitis A Vaccines / Q000627:therapeutic use; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000097:blood / Q000453:epidemiology*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D014611:Vaccination / Q000706:statistics & numerical data*
D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines